Minute Insight: Ganymed Raises Additional Cash To Further Contactless Surgical Robot
Ganymed is developing a robotic system that will help guide arthroplasty surgery.
You may also be interested in...
The company is developing a contactless surgical robot that can guide implant placement during orthopedic surgery.
The company has developed a technology that uses engineered DNA to reprogram cancer cells, forcing them to produce substances that could be used to help image, detect or even destroy them.
The Glasgow-based company has completed a large series A round to further develop its technology, which can be used to help save patients’ lives in the event of opioid overdose. Medtech Insight spoke to the Scottish National Investment Bank, one of the main investors, about the deal and its altruistic view of investment.